Virtual Seminar: Programming and Reprogramming: What Does It Take to Make a Cardiomyocyte?
Li Qian, Ph.D.
Associate Professor, Pathology and Lab Medicine
Associate Director of the McAllister Heart Institute
UNC School of Medicine
Virtual Pioneers in Biomedical Research Seminar: Programming and Reprogramming: What Does It Take to Make a Cardiomyocyte?
Feb. 25, 2022
11:00 a.m. to 12:00 p.m.
Archived video
About this Seminar
The incidence of myocardial infarction is the leading cause of morbidity and mortality around the world. The underlying pathology is typically loss of cardiomyocytes that leads to heart failure. Over the years, Dr. Qian and her lab have worked on the direct reprogramming approach that converts endogenous cardiac fibroblasts into cardiomyocyte-like cells (called iCMs) to replenish the lost cardiomyocytes in damaged hearts. By leveraging the knowledge that faithful cell fate conversion requires a precise dosage of transcriptional factors, the lab identified the optimal ratio of reprogramming factors for more complete and efficient iCM generation. Hypothesizing that reprogramming involves significant chromatin reorganization, Dr. Qian and her team profiled the epigenetic repatterning events during early iCM induction and identified epigenetic barriers to iCM conversion. More recently, they applied single-cell omics to overcome the difficulties of studying reprogramming due to the inherent nature of its heterogeneity and asynchrony. Through these efforts, Dr. Qian's lab has obtained novel insights into the transcriptional, posttranscriptional and epigenetic regulation of iCM reprogramming, and concomitantly improved the quality and yield of iCMs for future clinical application. They also anticipate that the experimental and analytical methods presented here, when applied in additional contexts, will yield crucial insights about cell fate determination and the nature of cell type identity.
Additional Details
This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Center for Vascular and Heart Research. The Pioneers in Biomedical Research Seminar Series, which runs annually from September to May, has featured leading biomedical researchers from throughout the country since the program began in 2012. The lectures are also open to all members of the Virginia Tech community including graduate students, undergraduates, faculty, and staff, as well as the public.
You May Also Be Interested In...
-
Home ItemBiobehavioral Susceptibility for Obesity: Behavioral, Genetic and Neuroimaging Studies of Appetite , home
Sept. 6, 2024, 11:00 a.m. | Susan Carnell, Ph.D., Associate Professor, Division of Child and Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine | Co-Sponsored by the Center for Health Behaviors Research and the Addiction Recovery Research Center, Fralin Biomedical Research Institute
-
Home ItemConducting the Neuro-Symphony in the Brain — Space, Time, and Calcium , home
Sept. 12, 2024, 5:30 p.m. (Reception at 5 p.m.) | Michael Friedlander, Ph.D., Executive Director, Fralin Biomedical Research Institute Vice President for Health Sciences and Technology, Virginia Tech Senior Dean for Research, Virginia Tech Carilion School of Medicine | Maury Strauss Distinguished Public Lecture
-
Home ItemDevelopment of Genome Editor Therapies for Angelman Syndrome , home
Sept. 13, 2024, 11:00 a.m. | Mark J. Zylka, Ph.D., W.R. Kenan, Jr. Distinguished Professor, University of North Carolina at Chapel Hill; Director, UNC Neuroscience Center | Co-Sponsored by the Center for Neurobiology Research, Fralin Biomedical Research Institute
-
Home ItemUnderstanding the Limits of Exercise Responsiveness in Older Adults , home
Sept. 20, 2024, 11:00 a.m. | Ian R. Lanza, Ph.D., Professor of Medicine, Mayo Clinic College of Medicine and Science | Co-Sponsored by the Center for Exercise Medicine Research, Fralin Biomedical Research Institute
-
Home ItemFrom Variant Functionality to Resistance in Cancer , home
Sept. 27, 2024, 11:00 a.m. | Tiki Hayes, Ph.D., Assistant Professor, Department of Molecular and Medical Pharmacology, UCLA David Geffen School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – D.C.
-
Home ItemDisrupting Health Care Using Deep Data and Remote Monitoring , home
Oct. 4, 2024, 11:00 a.m. | Michael Snyder, Ph.D., Professor, Genetics, Director, Center for Genomics and Personalized Medicine, Stanford Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Exercise Medicine Research